Skip to content

Salivary metabolomics studies of chronic obstructive pulmonary disease

Salivary metabolomics studies of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064091
Enrollment
Unknown
Registered
2022-09-26
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Normal lung function group:none
Healthy group:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with chronic obstructive pulmonary disease are in a clinically stable period; (2) Patients with periodontal disease are divided into moderate-severe; (3) 40 years old= age = 75 years old; (4) Clear consciousness, able to complete the questionnaire survey and cardiopulmonary function, periodontal condition assessment / examination;

Exclusion criteria

Exclusion criteria: (1) Have other systemic diseases such as bronchial asthma, heart disease, diabetes, kidney disease, liver function impairment and so on; (2) Have taken various anti-inflammatory drugs, immune preparations, systemic glucocorticoids, etc. in the past 3 months; (3) Have undergone periodontal treatment (cleansing, scraping, periodontal surgery, etc.) within 3 months; (4) There are less than 20 teeth left in the mouth or no remaining teeth in the mouth; (5) There is a history of coronary prosthesis or orthodontic treatment in the oral cavity; (6) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Differential metabolites of saliva;

Countries

China

Contacts

Public ContactTao Fan
Edward.fan@yeah.net18628158466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026